Загрузка...
Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review
Apatinib, a novel small molecule tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor-2, was approved for metastatic gastric adenocarcinoma in China in Oct 2014. This is the first report on its use for advanced colorectal cancer as a kind of third-line therapy to date....
Сохранить в:
| Опубликовано в: : | Onco Targets Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5823067/ https://ncbi.nlm.nih.gov/pubmed/29497319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S148412 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|